FDA approves new gene therapies for sickle cell disease

Host Stephen Henderson examines the groundbreaking new gene therapies approved by the U.S. Food and Drug Administration as a treatment option for sickle cell disease. Dr. Melissa Creary, assistant professor at the University of Michigan’s School of Public Health, sits down with Henderson to talk about the pros, cons and possible barriers of the new gene-editing therapy.